Company: HURA
Filing Date: 2025-02-07
Form Type: S-4
Source: 0001193125-25-022803
Chunk: 286

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-02-07
Form: S-4
Chunk 286
---
 unenforceable in an action, Kineta may incur additional costs associated with resolving such action in other jurisdictions, which could adversely affect Kineta’s business and financial condition. The Court of Chancery of the State of Delaware may also reach different judgments or results than would other courts, including courts where a stockholder considering an action may be located or would otherwise choose to bring the action, and such judgments may be more or less favorable to Kineta than its stockholders. Kineta may issue a substantial number of additional shares of common stock under an employee incentive plan. Any such issuances would dilute the interest of Kineta’s stockholders and likely present other risks. Kineta may issue additional shares of common stock under an employee incentive plan. The issuance of additional common stock:

| • |     | may significantly dilute the equity interests of Kineta’s investors; |

| • |     | could cause a change in control if a substantial number of shares of common stock are issued, which may affect, among other things, Kineta’s ability to use its NOL carry forwards, if any, and could result in the resignation or removal of Kineta’s present officers and directors; and |

| • |     | may adversely affect prevailing market prices for the common stock. |

Kineta Common Stock trades on an over-the-countermarket, which has adversely affected its stock price and the liquidity of its stock and could impact its ability to obtain financing could be impaired. Kienta’s common stock was suspended from trading on The Nasdaq Capital Market at the opening of business on September 19, 2024 and delisted from Nasdaq effective as of October 25, 2024. Since September 19, 2024, Kineta Common Stock has been trading on the OTC Pink Market under the symbol “KANT.” Such market is currently the only trading market for Kineta Common Stock, which subjects Kineta and its stockholders to certain significant risks including:

| • |     | limited availability of market quotations for Kineta Common Stock; |

| • |     | reduced liquidity for Kineta Common Stock, including reduced availability of buyers or sellers of Kineta Common Stock; |

| • |     | limited amount of news and analyst coverage or no coverage at all; |

170

| • |     | decreased ability to issue additional securities or obtain additional financing in the future; and |

| • |     | Kineta Common Stock is no longer a “covered security” under the National Securities Markets Improvement Act of 199